AP NEWS
Press release content from BusinessWire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Bucci Laser Vision Joins the AcuFocus IC-8® Lens Clinical Study for Patients with Cataracts

January 16, 2019

WILKES-BARRE, Pa.--(BUSINESS WIRE)--Jan 16, 2019--Frank A. Bucci Jr., M.D. at Bucci Laser Vision in Wilkes-Barre, Pa., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts.

“The IC-8 lens may represent a significant change for cataract patients, utilizing small aperture optics or the pinhole effect,” Dr. Bucci said. “The Bucci Laser Vision team is excited to be part of this important clinical trial.”

By the age of 65, an estimated 90% of people worldwide experience changes to the natural crystalline lens of the eye. The lens gradually becomes cloudy as a cataract develops leading to blurry vision and eventually vision loss. The only solution to a cataract is the surgical removal of the natural lens and its replacement with an artificial lens called an IOL. More than 25 million cataract procedures are performed worldwide each year. The majority of patients with cataracts are treated with a standard monofocal (single-focus) lens, which allows the patient to have excellent far vision; however, patients remain dependent on glasses for near and intermediate vision.

Dr. Frank A. Bucci, Jr. will be one of a select group of clinical investigators across the United States for the lens study. The IC-8 lens is a clear monofocal lens with a mini-ring placed in the center. The mini-ring has an opening, or pinhole, designed to increase the range of vision by extending the focus of light rays that enter the eye. The clinical study will determine if the IC-8 lens in one eye, when paired with a standard monofocal lens in the other eye, will provide near and intermediate vision in addition to far vision for cataract patients.

Bucci Laser Vision is now enrolling patients that meet the study eligibility criteria. Patients who comply with study commitments will be compensated. Some basic qualifications include the following:

At least 22 years of age. Have cataracts in both eyes. Are available, willing and able to participate in examinations and all follow-up study visits and appointments.

If you are interested in becoming a volunteer participant in the IC-8 lens clinical study, please contact Breanne Michalek at Bucci Laser Vision at (570) 270-5281 or at breanne@buccivision.com.

Frank A. Bucci, Jr., MD, established the Bucci Laser Vision Cataract & Refractive Surgery Center in 1998. He has performed over 35,000 microsurgical eye surgeries. Which include over 20,000 cataract and 6,000 multifocal intraocular implants. To learn more go to www.BucciVision.com or call 1-877-DR-BUCCI.

ABOUT ACUFOCUS & THE IC-8 IOL

AcuFocus, Inc., is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of vision. The IC-8 lens received its CE mark in 2014 and is available in select markets across Europe and Asia. Founded in 2001, AcuFocus is based in Irvine, Calif. For additional information about the IC-8 intraocular lens, visit www.ic8lensclinicalstudy.com or https://www.facebook.com/ic8lensclinicalstudy.

Caution: Investigational Device. Limited by Federal (or United States) law to investigational use.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190116005169/en/

CONTACT: Shelle Murach

Cunningham & Associates

714 206-4138

smurach@gmail.com

KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA

INDUSTRY KEYWORD: SURGERY HEALTH CLINICAL TRIALS MEDICAL DEVICES OPTICAL

SOURCE: Bucci Laser Vision

Copyright Business Wire 2019.

PUB: 01/16/2019 09:05 AM/DISC: 01/16/2019 09:05 AM

http://www.businesswire.com/news/home/20190116005169/en